Decreasing warfarin sensitivity during the first three months after heart valve surgery: Implications for dosing

Thrombosis Research

Volumn 125, Issue 3, 2010, Pages 224-229

  Meijer, K ^a,b   Kim, Y K ^a,c   Schulman, S ^a  

^a HHS General Hospital   (Canada)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c Soonchunhyang University   (South Korea)

Author keywords

Algorithm; Anticoagulation; Bioprosthetic heart valve; Heart valve surgery; Mechanical heart valve; Warfarin

Indexed keywords

AMIODARONE; WARFARIN;

ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG SENSITIVITY; HEART ATRIUM FIBRILLATION; HEART VALVE SURGERY; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

AGED; ANTICOAGULANTS; CASE-CONTROL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG MONITORING; FEMALE; FOLLOW-UP STUDIES; HEART VALVES; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; OUTPATIENTS; RETROSPECTIVE STUDIES; TIME FACTORS; WARFARIN;

EID: 76949107108     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.02.012     Document Type: Article

References (14)

1. Salem D.N., O'Gara P.T., Madias C., and Pauker S.G. American College of Chest Physicians. Valvular and structural heart disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133 (2008) 593S-629S
2. Kulik A., Rubens F.D., Wells P.S., Kearon C., Mesana T.G., van Berkom J., et al. Early postoperative anticoagulation after mechanical valve replacement: a systematic review. Ann Thorac Surg 81 (2006) 770-781
3. Ageno W., and Turpie A.G. Exaggerated initial response to warfarin following heart valve replacement. Am J Cardiol 84 (1999) 905-908
4. Rose J.P., Rihn T.L., and Long S.F. Warfarin sensitivity after mechanical heart valve replacement. Pharmacotherapy 18 (1998) 856-859
5. Rahman M., BinEsmael T.M., Payne N., and Butchart E.G. Increased sensitivity to warfarin after heart valve replacement. Ann Pharmacother 40 (2006) 397-401
6. Cade J.F., Hirsh J., and Clarebrough J.K. Anticoagulants after open-heart surgery. Med J Aust 2 (1970) 5-6
7. Rosendaal F.R., Cannegieter S.C., Van der Meer F.J., and Briët E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 69 (1993) 236-239
8. Ionescu M.I., Smith D.R., Hasan S.S., Chidambaram M., and Tandon A.P. Clinical durability of the pericardial xenograft valve: ten years experience with mitral replacement. Ann Thorac Surg 34 (1982) 265-277
9. Orszulak T.A., Schaff H.V., Pluth J.R., Danielson G.K., Puga F.J., Ilstrup D.M., et al. The risk of stroke in the early postoperative period following mitral valve replacement. Eur J Cardiothorac Surg 9 (1995) 615-619
10. Schulman S., El Bouazzaoui B., Eikelboom J.W., and Zondag M. Clinical factors influencing the sensitivity to warfarin when restarted after surgery. J Intern Med 263 (2008) 412-419
11. Franco V., Polanczyk C.A., Clausell N., and Rohde L.E. Role of dietary vitamin K intake in chronic oral anticoagulation: prospective evidence from observational and randomized protocols. Am J Med 116 (2004) 651-656
12. Parker C.S., Chen Z., Price M., Gross R., Metlay J.P., Christie J.D., et al. Adherence to warfarin assessed by electronic pill caps, clinician assessment, and patient reports: results from the IN-RANGE study. Gen Intern Med 22 (2007) 1254-1259
13. Ansell J., Hirsh J., Hylek E., Jacobson A., Crowther M., and Palareti G. American College of Chest Physicians. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133 (2008) 160S-198S
14. Fitzmaurice D.A., Kesteven P., Gee K.M., Murray E.T., and McManus R. A systematic review of outcome measures reported for the therapeutic effectiveness of oral anticoagulation. J Clin Pathol 56 (2003) 48-51